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Cell Biology
Integration of multiple instructive cues by neural crest
stem cells reveals cell-intrinsic biases in relative
growth factor responsiveness
NIRAO M. SHAH* AND DAVID J. ANDERSON†
Division of Biology 216-76, Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125
Communicated by Melvin I. Simon, California Institute of Technology, Pasadena, CA, August 5, 1997 (received for review June 18, 1997)
ABSTRACT Growth factors can inf luence lineage deter-
mination of neural crest stem cells (NCSCs) in an instructive
manner, in vitro. Because NCSCs are likely exposed to multiple
signals in vivo, these findings raise the question of how stem
cells would integrate such combined inf luences. Bone mor-
phogenetic protein 2 (BMP2) promotes neuronal differentia-
tion and glial growth factor 2 (GGF2) promotes glial differ-
entiation; if NCSCs are exposed to saturating concentrations
of both factors, BMP2 appears dominant. By contrast, if the
cells are exposed to saturating concentrations of both BMP2
and transforming growth factor b1 (which promotes smooth
muscle differentiation), the two factors appear codominant.
Sequential addition experiments indicate that NCSCs require
48–96 hrs in GGF2 before they commit to a glial fate, whereas
the cells commit to a smooth muscle fate within 24 hr in
transforming growth factor b1. The delayed response to GGF2
does not ref lect a lack of functional receptors; however,
because the growth factor induces rapid mitogen-activated
protein kinase phosphorylation in naive cells. Furthermore,
GGF2 can attenuate induction of the neurogenic transcription
factor mammalian achaete-scute homolog 1, by low doses of
BMP2. This short-term antineurogenic inf luence of GGF2 is
not sufficient for glial lineage commitment, however. These
data imply that NCSCs exhibit cell-intrinsic biases in the
timing and relative dosage sensitivity of their responses to
instructive factors that inf luence the outcome of lineage
decisions in the presence of multiple factors. The relative delay
in glial lineage commitment, moreover, apparently ref lects
successive short-term and longer-term actions of GGF2. Such
a delay may help to explain why glia normally differentiate
after neurons, in vivo.
The diverse cell types of complex tissues such as the blood and
the brain are thought to be generated from self-renewing
multipotent progenitors called stem cells (1). These stem cells
must generate progeny of different phenotypes, in the correct
proportions, sequence, and location. The manner in which this
is accomplished is not understood. It is clear that the local
microenvironment of stem cells has an important influence on
their behavior. In most systems, however, the identity of key
environmental influences and the nature of their effects on
stem cells is not clear.
Previously, we isolated and characterized self-renewing mul-
tipotent progenitor cells from the mammalian neural crest (2).
In vitro, these neural crest stem cells (NCSCs) are able to
generate autonomic neurons, Schwann (glial) cells, and
smooth muscle (SM)—three cell types derived from the neural
crest in vivo (3). Subsequently, we identified three growth
factors that promote differentiation along each of these three
lineages, respectively: bone morphogenetic protein 2 (BMP2),
glial growth factor 2 [GGF2, a neuregulin (4)], and transform-
ing growth factor b1 (TGF-b1) (5, 6). Clonal analysis and serial
observation of identified cells has suggested that each of these
factors acts instructively rather than selectively on NCSCs (5,
6) [although some of the factors may do both (7)]. In other
words, GGF2, BMP2, and TGF-b1 individually directed the
differentiation rather than the survival or proliferation of the
majority of individual identified NCSCs plated at clonal den-
sity. The neural crest thus represents one of the few systems in
which instructive lineage determination signals for multipo-
tential stem cells have been identified (for review, see ref. 1).
It is likely that in vivo NCSCs and other stem cells are
exposed to multiple environmental signals. It is, therefore,
important to understand how the stem cells integrate such
competing influences. We now have performed experiments in
which NCSCs are exposed to different combinations of in-
structive signals. In principle, four outcomes to such experi-
ments are possible: (i) the influence of one signal could
dominate over others; (ii) the signals could exert equivalent
influences, producing a mixture of lineage-committed prog-
eny; (iii) the signals could nullify each others’ influence,
thereby inhibiting differentiation; or (iv) the combination of
signals could generate new differentiated phenotypes not seen
with any individual signal alone. Our results indicate that each
of the first two possible outcomes can be obtained, depending
upon the specific combination and concentration of signals
tested. These data therefore suggest that stem cell fate is not
solely determined by what factors are present in the environ-
ment but also is influenced by cell-intrinsic differences in the
relative sensitivity and timing of responses to different envi-
ronmental signals.
MATERIALS AND METHODS
NCSC Cultures. NCSCs were obtained and cultured at
clonal density on a poly-D-lysineyfibronectin substrate as de-
scribed (2, 6). Briefly, trunk neural tubes from embryonic day
10.5 rat fetuses were isolated by using collagenase dissociation
(2). Tubes were plated on a fibronectin substrate in L15-CO2
medium containing 10% chicken embryo extract (CEE) and
additives as described (2). Neural crest cells were obtained
from trypsinized primary explants and re-plated on a poly-D-
lysineyfibronectin substrate (2) in medium containing 15%
CEE, and grown in a 6% CO2y94% air atomosphere. The cells
were allowed to attach for 6–8 hr before adding supplemen-
tary growth factors. Mixing of growth factors was always
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performed before addition to the culture medium. In exper-
iments involving treatment with TGF-b1, or TGF-b1 followed
by BMP2, colonies were established on a fibronectin-only
substrate because this allowed better survival of cells. Quali-
tatively similar results were obtained on pdLyFN, however.
Sources of the growth factors were as described (5, 6). The
activities of new lots of each factor were determined by
dose–response experiments. Saturating responses were ob-
tained at 1 nM GGF2, 2 nM BMP2, and 20 pM TGF-b1,
consistent with our previous results (5, 6). The effects of these
factors on differentiation was assessed after 5 days, a time at
which spontaneous differentiation of NCSCs to neurons and
SM is not yet detectable (2, 6).
Immunocytochemistry. Mouse mAbs to low-affinity neuro-
trophin receptor (p75LNTR), mammalian achaete-scute ho-
molog 1 (MASH1), glial fibrillary acidic protein, and a-SM
actin (aSMA) and rabbit polyclonal antibody to peripherin
were used as described (2, 5, 6). Not all SMs are aSMA1 (6);
in such cases, SMs were identified on the basis of their
characteristic morphology and lack of immunoreactivity for
neuronal, glial, and NCSC markers (6). To assess the inhibitory
effects of GGF and TGF-b on neuronal differentiation, ‘‘neu-
ronal’’ colonies were conservatively defined as containing at
least one peripherin1 process-bearing cell (although typical
neuronal colonies usually contained many more than one
neuron). Some neuronal colonies contained SM cells but no
LNTR1 cells (6). Neuron-only and neuronal colonies were
scored in aggregate for this analysis. SM colonies contained
only SM cells (6).
For the mitogen-activated protein kinase (MAPK) phos-
phorylation assay, 250-1,000 NCSCs were plated in the center
of a 12-well Corning dish. After an 8- to 10-hr incubation in
control medium (2), growth factors were added to the wells
without removing the dish from the incubator. An equal
volume of carrier solution without factor was added to some
wells as a control. Dishes were agitated to ensure even
distribution of the growth factor. (This entire procedure took
1–2 min.) The timer was started and dishes were fixed 10, 20,
and 60 min later. Activated MAPK was detected with a rabbit
polyclonal antibody (Promega; 1 mgyml) by the manufacturer’s
recommendations. Staining was visualized with an horseradish
peroxidase-conjugated secondary antibody and nickelous sul-
fatey3,39-diaminobenzidine histochemistry.
RESULTS
NCSCs Exhibit Dosage-Sensitive Interactions Between
GGF2 or TGF-b1 and BMP2. We first examined the ability of
two signals that individually promote nonneurogenic fates,
GGF2 and TGF-b1, to interfere with autonomic neurogenesis
promoted by BMP2. Initially, we used concentrations of each
growth factor at or just below saturation for their respective
differentiation effects on NCSCs (5, 6). Strikingly, in the
presence of BMP2 plus GGF2, glial differentiation was sup-
pressed, and the majority (65%) of colonies were neuronal
(Fig. 1, BMP21GGF2, and Fig. 2A, compare GGF2 vs.
BMP21GGF2, hatched and black bars). A similar result was
obtained even if the concentration of GGF2 was increased
5-fold (to 5 nM), a concentration well above saturation for
both glial differentiation and Schwann cell mitogenesis (5)
(Fig. 2A, compare 5xGGF2 vs. BMP215xGGF2, black and
hatched bars). We noted a slight increase in the percentage of
SM colonies in BMP21GGF2 compared with BMP2 alone
(Fig. 2A, open bars). This may reflect an effect of GGF2 to
weakly inhibit the neurogenic activity of BMP2 (see below);
however, the trend did not continue with increasing concen-
trations of GGF2 (Fig. 2 A, BMP215XGGF2, open bars).
Nevertheless, this result does not alter the basic conclusion that
FIG. 1. BMP2 is dominant over GGF2 at saturating concentrations of both factors. (A) NCSCs were grown for 15 days at clonal density under
the indicated conditions and analyzed by immunocytochemistry for expression of glial fibrillary acidic protein (GFAP; redyphycoerythrin) and
peripherin (greenyf luorescein isothiocyanate). Due to the large size of the colonies, only parts of colonies are depicted. Both neurons and glia have
differentiated in control (no addition) cultures (NA). In GGF2 (1 nM)-treated cultures, only GFAP1 glia are seen, but in either BMP2 (2 nM)
or BMP2&GGF2, peripherin1 neurons, but not glia, are observed.
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gliogenesis but not neurogenesis is blocked in the presence of
saturating doses of both GGF2 and BMP2.
A very different result was obtained when NCSCs were
cultured in BMP2 plus TGF-b1. In this case, a response
intermediate to that obtained with either factor alone was
observed: roughly half the colonies were neuronal, and the
remainder contained SM (Fig. 2B, BMP21TGF-b1, compare
solid vs. open bars). By contrast, in BMP2 alone, 75–80% of
colonies contained neurons and the remainder were SM (Fig.
2B, BMP2, solid bars), whereas in TGF-b1 alone .90% of
colonies were SM (Fig. 2B, TGF-b1, open bars). Undifferen-
tiated NCSCs, identified by expression of p75LNTR, were not
observed in any of these conditions (Fig. 2B, hatched bars),
although the majority of control colonies consisted of such
cells (data not shown). By this criterion, therefore, most or all
NCSCs have exited the stem cell state in the presence of
TGF-b1, BMP2, or both factors. Increasing the concentration
of TGF-b1 by 5-fold (100 pM) led to an increase in the
percentage of SM colonies and a corresponding drop in the
proportion of neuronal colonies (Fig. 2 B, compare
BMP21TGF-b1 vs. BMP215xTGF-b1, open vs. solid bars).
Increasing the concentration of BMP2 5-fold (to 10 nM) only
slightly increased the proportion of neuronal colonies (Fig. 2B,
compare BMP21TGF-b1 vs. 5xBMP21TGF-b1). These data
suggest that when NCSCs are grown in BMP21TGF-b1, the
influence of the two factors is codominant and reflects, at least
to some extent, their relative concentrations.
The foregoing observations suggested that NCSCs integrate
the combined influences of GGF2 and BMP2 vs. TGF-b1 and
BMP2 very differently. To determine whether the apparent
dominance of BMP2 over GGF2 was absolute or was depen-
dent on the concentration of BMP2, we asked whether GGF2
(at a saturating dose of 1 nM) could inhibit neurogenesis
promoted by subsaturating doses of BMP2. At 50-fold lower
concentrations of BMP2 (40 pM), GGF2 was indeed able to
reduce the percentage of neuronal colonies, from 77 6 4 to
39 6 5% (Table 1). However, even at 20 pM BMP2, GGF2 did
not completely suppress neurogenesis (Table 1).
NCSCs Lose Neurogenic Capacity with Different Kinetics
in GGF2 vs. TGF-b1. The preceding results raised the question
of why GGF2 is relatively weaker than TGF-b1 in its ability to
interfere with neurogenesis promoted by BMP2. On the one
hand, this could reflect differences in the relative sensitivity of
the cells to these growth factors. On the other hand, it could
reflect differences in the temporal windows in which NCSCs
are competent to respond to the different factors. For example,
although NCSCs are able to respond to BMP2 within 6–12 hr,
as assayed by induction of the autonomic lineage-specific (8)
transcription factor MASH1 (6), NCSCs or their progeny may
only acquire GGF2 responsiveness after several days in vitro.
If, in subsaturating doses of BMP2, commitment to neurogen-
esis occurs stochastically and asynchronously (9), some NCSCs
would escape the influence of BMP2 during the first few days
of culture. These uncommitted cells then could acquire re-
sponsiveness to GGF2. In contrast, in saturating concentra-
tions of BMP2, all cells would commit to a neuronal fate before
they had a chance to become GGF2-responsive, so that no
effect of the latter factor would be observed.
To distinguish these possibilities, we carried out experiments
in which NCSCs were exposed sequentially to GGF2 and
BMP2 or to TGF-b1 and BMP2. We measured the kinetics
with which the cells lost neurogenic capacity by assaying their
ability to express MASH1 protein [which is essential for
autonomic neurogenesis (10)] in response to a subsequent
addition of BMP2. Because neither Schwann cells nor SM cells
express MASH1 when exposed to BMP2 (N.M.S., unpublished
results), the loss of MASH1 inducibility provides an indirect
FIG. 2. Dosage-sensitive interactions between GGF2 or TGF-b1
and BMP2. (A) Quantitative analysis of NCSC differentiation in
saturating concentrations of GGF2 (1 nM) and BMP2 (2 nM).
Colonies were analyzed after 5 days, by which time BMP2 has induced
overt neuronal differentiation (6), by triple labeling with antibodies to
p75LNTR, peripherin, and a-SM actin. LNTR1colonies (hatched bars)
contained no neurons. Peripherin1 colonies (solid bars) contained
neurons and in some cases SM cells, but no LNTR1 nonneuronal cells;
SM colonies (open bars) contained only SM cells. Note that no
LNTR1 colonies developed in BMP2 plus any concentration of GGF2
tested. 5xGGF2, 5 nM GGF2; 5xBMP2, 10 nM BMP2. The results
represent the mean 6 SEM of two experiments; '20 colonies per
condition per experiment were analyzed. (B) Quantitative analysis of
NCSC differentiation in saturating concentrations of BMP2 (2 nM)
and TGF-b1 (20 pM). Cultures were assayed as described for A.
Table 1. Suppression of neuronal differentiation and induction of






BMP2 (2 nM) 81 6 2 95 6 5
BMP2 (2 nm) 1 GGF2 (1 nM) 86 6 2 94 6 6
BMP2 (40 pM) 77 6 4 77 6 4
BMP2 (40 pM) 1 GGF2 (1 nM) 39 6 5 69 6 9
BMP2 (20 pM) 62 6 7 76 6 4
BMP2 (20 pM) 1 GGF2 (1 nM) 17 6 3 30 6 2
BMP2 (4 pM) 6 6 3 39 6 6
BMP2 (4 pM) 1 GGF2 (1 nM) 0 7 6 3
Control 0 5 6 1
GGF2 (1 nM) 0 0
Neural crest cells were grown at clonal density in the presence of
BMP2 at the indicated concentrations, either alone or in the presence
of 1 nM GGF2. The cultures for determining neuronal colonies were
fixed after 5 days and the percentage of neuronal (i.e., neuron
containing) colonies determined after staining for peripherin. The
cultures for MASH11 colonies were fixed after 24 hr and immuno-
stained for MASH1; the percentage of total colonies containing $1
MASH11 cell was scored. The results represent the mean 6 SEM of
two experiments, in which 25–30 colonies per experiment were scored.
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index of the kinetics of commitment of NCSCs to these
nonneuronal lineages.
When BMP2 and TGF-b1 were added simultaneously, the
proportion of colonies expressing MASH1 after 24 hr was
already reduced, from about 85% to 45% (Fig. 3A, 0 hr,
hatched bar), consistent with the fact that TGF-b1 reduced the
extent of overt neuronal differentiation measured after 5 days
of growth in the presence of both factors (Fig. 2B,
BMP21TGF-b1). If BMP2 was added 24 hr after TGF-b1,
moreover, only '15% of colonies expressed MASH1 (Fig. 3A,
24 hr, hatched bar). If BMP2 was added 48 hr after TGF-b1,
virtually none of the colonies expressed MASH1 (Fig. 3A, 48
hr, hatched bar). By contrast, in control cultures grown without
TGF-b1, delayed addition of BMP2 at any of these times
induced MASH1 in most colonies (Fig. 3A, solid bars). Thus,
NCSCs rapidly lose responsiveness to BMP2 if preincubated in
TGF-b1. The kinetics of this change, and an estimated cell
cycle time of 12–18 hr for NCSCs (2), further implies that
NCSCs or their immediate progeny are responsive to TGF-b1
in the same time window as they are responsive to BMP2 (6).
Consistent with this idea, if NCSCs were, conversely, first
cultured in BMP2 for 24 hr and then exposed to TGF-b1, the
extent of SM differentiation promoted by TGF-b1 was greatly
attenuated (data not shown).
A very different kinetic profile was observed if NCSCs first
were grown in GGF2 alone and subsequently assayed for
expression of MASH1 after a 24-hr exposure to BMP2. In this
case, preincubation in GGF2 for 24 hr produced no apparent
diminution in the extent of MASH1 induction elicited by
subsequent exposure to BMP2 (Fig. 3B, 24 hr, solid vs. hatched
bars). Furthermore, even after 48 and 96 hr of exposure to
GGF2, a significant fraction of colonies expressed MASH1 in
response to BMP2 (Fig. 3B, 48 and 96 hr, hatched bars;
although by 96 hr, the proportion of MASH11 cells within
these colonies was reduced to '5%). Importantly, in control
conditions, the ability to respond to delayed addition of BMP2
by induction of MASH1 was retained for at least 96 hr (Fig. 3B,
solid bars). Therefore, the loss of MASH1 inducibility in the
presence of GGF2 was indeed caused by the growth factor and
was not simply a spontaneous gradual loss of BMP2 respon-
siveness by NCSCs. However, this loss of neurogenic capacity
FIG. 3. NCSCs lose BMP2 responsiveness in TGF-b1 more rapidly
than they do in GGF2. (A) Hatched bars: BMP2 (2 nM) was added
simultaneously with (0 hr) or 24 or 48 hr after addition of TGF-b1 (20
pM). The proportion of colonies containing any MASH11 cells was
determined 24 hr later by staining with anti-MASH1 antibody. Solid
bars: BMP2 was added at the indicated times to control cultures grown
without TGF-b1. No MASH1 expression was detected in cultures
grown in TGF-b1 alone (data not shown). (B) Analogous experiment
in which BMP2 was added simultaneously with or at the indicated
times after addition of GGF2 (1 nM). No MASH1 expression was
detected in cultures grown in GGF2 alone (data not shown). Note that
almost 50% of the colonies contain some MASH11 cells even if BMP2
is added 48 hr after GGF2. If BMP2 was added after 96 hr in GGF2,
'45% of colonies still contained some MASH11 cells (hatched bars).
(However, only '5% of cells within these colonies were MASH11 vs.
50% MASH11 cells per colony in cultures grown without GGF2 for
96 hr.) Thus most cells within colonies lose the ability to express
MASH1 in response to BMP2 after 48–96 hr in GGF2. Data represent
the mean 6 SEM of two experiments; '20 colonies were analyzed per
experiment for each time and condition shown.
FIG. 4. GGF2 induces rapid phosphorylation of MAPK in freshly
isolated NCSCs. Columns 2 and 4 represent bright-field views of the
phase-contrast views in columns 1 and 3, respectively. Cells in row A
were fixed before any factor was added; activated MAPK is not
expressed in cells at this time. Cells in row B received GGF2 (1 nM),
cells in row C received BMP2 (2 nM), and cells in row D were treated
with GGF21BMP2. Cells in columns 1 and 2 were treated with growth
factor(s) for 10 min, and cells in columns 3 and 4 were treated with
growth factor(s) for 60 min. (B) Quantification of induction of
phosphorylated MAPK by GGF2 in NCSCs. The results represent the
mean 6 SEM of two experiments.
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in GGF2 required 48–96 hr of exposure to the growth factor,
whereas it occurred in less than 24 hr in TGF-b1.
We addressed the possibility that selective cell death during
the preincubation in GGF2 could account for the loss of BMP2
responsiveness. However, after 72 hr in GGF2, only 30 6 10%
of colonies contained any dead cells (identified by 4,6-
diamidino-2-phenylindole staining for fragmented apoptotic
nuclei), and within these colonies only 3.5% of cells were dead.
By contrast during this period, 55–60% of colonies have lost
the ability to respond to BMP2 by expression of MASH1 (Fig.
3B), and within individual colonies, 85–90% of cells fail to
express MASH1 in response to BMP2. These data argue that
a selective death of BMP2-responsive cells is unlikely to
explain the loss of MASH1 inducibility by NCSCs cultured in
GGF2. Rather, the loss of BMP2 responsiveness likely reflects
the gradual commitment of the cells to a nonneurogenic (e.g.,
glial) fate.
Freshly Isolated NCSCs Exhibit a Rapid Direct Response to
GGF2. One simple explanation for the delayed loss of neuro-
genic capacity in GGF2 would be that NCSCs are not com-
petent to respond to the growth factor during their first 48 hr
in vitro. To address this question, we asked whether GGF2 can
cause phosphorylation of MAPK in freshly isolated NCSCs, by
using an antibody that recognizes only the doubly phosphor-
ylated active form of MAPK (MAPKyPO4) (11). Within 10
min of exposure to GGF2 (the earliest time tested), MAPKy
PO4 was detected in '80% of the cells (Fig. 4 A, sections B1
and B2, and B). In many cells, MAPKyPO4 appeared con-
centrated in the nucleus (Fig. 4A, section B2). Expression of
MAPKyPO4 was sustained for 20 min after GGF2 addition
(Fig. 4B), but by 60 min was no longer detectable (Fig. 4 A,
sections B3 and B4, and B). Induction of MAPK phosphory-
lation by GGF2 was not blocked by simultaneous addition of
BMP2 (Fig. 4 A, sections D1 and D2 and B), indicating that the
dominant influence of BMP2 over GGF2 (Figs. 1 and 2 A) is
not due to a complete suppression of early GGF2-mediated
signal transduction events. These data reveal that freshly
isolated NCSCs respond directly to GGF2. Therefore, the
delayed loss of neurogenic capacity in GGF2 (Fig. 3B) cannot
be explained by a delayed acquisition of functional GGF2
receptors.
GGF2 Inhibits Induction of MASH1 by Subsaturating
Doses of BMP2. The ability of GGF2 to induce rapid MAPK
phosphorylation in NCSCs left open the question of whether
the growth factor influences the differentiative behavior of the
cells during the first 24–48 hr in vitro. For example, the cells
might lack other components necessary for glial lineage com-
mitment that only become expressed after 48 hr of culture in
GGF2. However, early molecular markers of committed glial
cells are currently unavailable. We therefore asked whether
GGF2 could interfere with early events in neuronal differen-
tiation, by using induction of MASH1 expression after 24 hr as
a short-term assay for the neurogenic influence of BMP2.
As expected, GGF2 (1 nM) had no effect on MASH1
induction after 24 hr in a saturating concentration of BMP2
(Table 1), consistent with its inability to block overt neuronal
differentiation after 5 days in a similar dose of BMP2 (Fig. 2 A).
However, GGF2 did significantly attenuate induction of
MASH1 by subsaturating doses of BMP2. For example, in 20
pM BMP2, 76 6 4% of colonies contained some MASH11
cells, but this was reduced to 30 6 2% in the presence of 1 nM
GGF2 (Table 1). These data indicate that GGF2 is able to
exert a negative influence on neurogenesis by NCSCs within
the first 24 hr in culture. Interestingly, however, the attenua-
tion of MASH1 induction by GGF2 was not as great as the
attenuation of neuronal differentiation: for example, at 40 pM
BMP2, GGF2 reduced the proportion of neuronal colonies
from 77 6 4 to 39 6 5%, whereas it produced a statistically
insignificant reduction in the proportion of MASH11 colonies
at this BMP2 concentration (77 6 4 vs. 69 6 9%; Table 1). This
suggests that the inhibitory effect of GGF2 on BMP2-induced
neurogenesis cannot be explained solely by its ability to inhibit
induction of MASH1 expression; perhaps, for example, GGF2
also inhibits the function of MASH1, or the expression of other
factors necessary for neuronal differentiation.
Taken together, the results in Table 1 and Fig. 3B imply that
the short-term inhibition by GGF2 of MASH1 induction at low
doses of BMP2 is insufficient to commit NCSCs to a glial fate.
To demonstrate this, cells first were grown for 24 hr in 1 nM
GGF2 plus a low dose of BMP2, then challenged with a second
addition of BMP2 at 2 nM, and assayed 24 hr later for
induction of MASH1. No significant diminution in the extent
of MASH1 induction by this second addition of saturating
BMP2 (data not shown) resulted, confirming that the cells had
not committed to a glial fate during the preincubation period
despite the initial inhibition of MASH1 induction. This result
was identical to that obtained when NCSCs were cultured in
GGF2 alone for 24 hr and then challenged with 2 nM BMP2
(Fig. 3B), indicating that the presence of a low dose of BMP2
in the mixed factor preincubation did not interfere with the
effect of GGF2. These data imply that although GGF2 is able
to exert an inhibitory effect on the neurogenic influence of
BMP2 within the first 24 hr in vitro, the action revealed by this
negative effect is not sufficient to commit the cells to a glial
fate. Such an irreversible restriction appears to depend on
longer-term consequences of GGF2 action, which require
48–96 hr of continuous exposure to the growth factor.
DISCUSSION
In this study, we have used neural crest cells as a model system
to understand how multipotent stem cells integrate the influ-
ences of competing instructive signals for lineage determina-
tion. Our results indicate that two determinants of nonneuro-
nal fates, TGF-b1 and GGF2, differ markedly in their ability
to override the neurogenic influence of BMP2: at saturating
concentrations of all ligands, the influence of BMP2 is dom-
inant over that of GGF2, whereas it appears codominant with
that of TGF-b1. Moreover, NCSCs commit to SM or neuronal
fates in TGF-b1 and BMP2, respectively, much more rapidly
than they do to a glial fate in GGF2. These results indicate that
intrinsic biases in NCSCs can affect the outcome of lineage
decisions made in the presence of multiple competing instruc-
tive signals.
TGF-b1, but not GGF2, is able to inhibit induction of
MASH1 by saturating concentrations of BMP2 (Fig. 3, 0 hr).
However, at a 100-fold lower concentration of BMP2, GGF2
is able to partially inhibit induction of MASH1 (Table 1).
These data suggest that NCSCs differ in their intrinsic relative
sensitivities to different instructive growth factors. They also
suggest that the signal transduction pathways for these factors
may be linked by reciprocal inhibitory interactions that differ
in their relative strength. The molecular basis of these differ-
ences is unknown. It could reflect the relative number of
receptors per cell for each growth factor, the threshhold levels
of signaling necessary to elicit their respective biological
responses, or other regulatory mechanisms.
The difference in the ability of TGF-b1 and GGF2 to
compete with BMP2 is not simply a function of relative dosage
sensitivities, however, but also is influenced by differences in
the relative kinetics of commitment to the SM and glial fates.
NCSCs undergo a restriction in their neurogenic capacity
within 24 hr in TGF-b1, whereas this restriction is not apparent
until after .48 hr in GGF2. Our results set some constraints
on the mechanisms underlying this apparent delay in glial
lineage commitment. Specifically, it cannot be due simply to a
delayed expression of functional receptors for GGF2, because
the growth factor is able to both activate phosphorylation of
MAPK and also to inhibit induction of MASH1 by low doses
of BMP2; both effects are detected in the first 24 hr in vitro.
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Other explanations therefore are necessary to account for
the delayed loss of neurogenic capacity in GGF2. One parsi-
monious model is that it involves loss of a critical signaling
component for BMP2, such as the receptors. If GGF2 caused
a rapid inhibition of BMP2 receptor expression, for example,
then the time required for the cells to lose BMP2 responsive-
ness would be determined by the initial number of receptors on
the cells and the kinetics of degradation of these receptors. A
testable prediction of this model is that constitutive expression
of BMP receptors in NCSCs should prevent loss of neurogenic
capacity in GGF2. Another possibility is that NCSCs have to
undergo a certain number of cell divisions in GGF2 to lose
BMP2 responsiveness. Testing such a model is less straight-
forward, however, because mitotic inhibitors appear toxic to
NCSCs (N.M.S., unpublished results).
Why do NCSCs lose neurogenic capacity more rapidly in
TGF-b1 than in GGF2? As TGF-b1 and BMP2 use related
signal transduction pathways (12), these pathways may operate
with similar kinetics and compete for shared components. For
example, a family of proteins called Smads has recently been
identified as mediating signal transductions events specific to
TGF-b and BMP2y4 (13). One of these proteins, Smad4y
DPC4, is thought to serve as a common heterodimeric partner
for other Smads specific to TGF-b or BMP2 (14, 15). Com-
petition for limiting amounts of this common partner could
thus explain the ability of TGF-b to inhibit BMP2-specific
signaling, an hypothesis testable by overexpression of Smad4y
DPC4.
The data presented herein shed light on the mechanism of
GGF2 action on NCSCs. Previously, the effects of GGF2 were
assayed after 6–15 days of culture, by examining the expression
of phenotypic markers specific for neurons (or their precur-
sors) and glia (5). From such data it was not possible to
determine when GGF2 first influences NCSCs and whether
this influence is primarily positive (to promote gliogenesis),
negative (to inhibit neurogenesis), or both. The ability of
GGF2 to attenuate MASH1 induction by low doses of BMP2
provides evidence that GGF2 can exert an inhibitory influence
on neurogenesis by NCSCs in the first 24 hr of culture. This
does not exclude the possibility that GGF2 also exerts early
positive effects on gliogenesis, although molecular markers of
such effects have yet to be identified. Moreover, our results
indicate that these short-term influences of GGF2 are insuf-
ficient to commit NCSCs to a glial fate; therefore, other
unknown events must occur upon further exposure to GGF2
that cause an irreversible loss of neurogenic capacity. It will be
interesting to determine whether factors that promote glio-
genesis by central nervous system stem cells (16–18) also exert
such sequential effects.
Finally, our results may help to explain why, in vivo, neu-
rogenesis invariably precedes gliogenesis (19). NCSCs commit
to a neuronal fate in response to BMP2 far more rapidly than
they commit to a glial fate in GGF2. Furthermore, the
influence of BMP2 is dominant over that of GGF2 when both
factors are present at saturating amounts. Thus if migrating
neural crest cells encountered an environment containing both
BMP2 and GGF2, they likely would differentiate into neurons
first. This immediately raises the problem of what mechanism
would prevent the entire pool of crest cells from differentiating
into neurons. We have suggested (5) that a negative feedback
signal derived from neurons, possibly mediated by GGF, could
inhibit neurogenesis in neighboring uncommitted cells. If the
local concentration of BMP2 declined with time to subsatu-
rating levels, our results suggest that GGF2 would be able to
inhibit the influence of this neurogenic signal to promote
gliogenesis in the remaining stem cell pool. Alternatively,
multiple negative feedback signals may act in concert to
override neuronal inducing signals in vivo. Expression of
activated forms of NOTCH inhibits neurogenesis, but not
gliogenesis, by some multipotent progenitor cells in vitro (20).
It will be interesting to determine whether ligands for NOTCH
proteins, such as Delta-1 (21), function cooperatively with
factors such as GGF2 to suppress neurogenesis in NCSCs.
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